Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and Fc gamma RIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and Fc gamma RIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Gagez A-L, Tuaillon E., Cezar R., Dartigeas C., Mahe B., Letestu R., Maisonneuve H., Gouilleux-Gruart V., Bollore K., Ferrant E., Aurran T., Feugier P., Lepretre S., Cartron G. |
| Journal | BLOOD CANCER JOURNAL |
| Volume | 6 |
| Pagination | e389 |
| Date Published | JAN |
| Type of Article | Letter |
| ISSN | 2044-5385 |
| DOI | 10.1038/bcj.2015.115 |